Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience-Reference-Cited by-同舟云学术

Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience

Published:2020-09-30 Issue:3 Volume:35 Page:587-594
ISSN:2093-596X
Container-title:Endocrinology and Metabolism
language:en
Short-container-title:Endocrinol Metab

Author:

Kim Mijin^ORCID,Yoon Jee Hee^ORCID,Ahn Jonghwa,Jeon Min Ji,Kim Hee Kyung,Lim Dong Jun,Kang Ho-Cheol,Kim In Joo,Shong Young Kee,Kim Tae Yong^ORCID,Kim Bo Hyun^ORCID

Publisher

Korean Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://e-enm.org/upload/pdf/enm-2020-687.pdf

Reference23 articles.

1. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013

2. Prognosis of medullary thyroid carcinoma

3. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine

4. Postoperative radiotherapy for advanced medullary thyroid cancer—Local disease control in the modern era

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world clinical profile, RET mutation testing, treatments and patient-related outcomes for medullary thyroid cancer in Europe;European Thyroid Journal;2024-01-08

2. Alternative and efficient one-pot three-component synthesis of substituted 2-aryl-4-styrylquinazolines/4-styrylquinazolines from synthetically available 1-(2-aminophenyl)-3-arylprop-2-en-1-ones: characterization and evaluation of their antiproliferative activities;RSC Advances;2024

3. Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET;Cancers;2023-10-05

4. Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea;Current Oncology;2023-03-03

5. Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors;Endocrine-Related Cancer;2023-01-24